medisourceasia.com

Industry News


Home

About 
medisourceasia

Magazine
Industry News
Global Trends
Events Calendar
Web Links

Web Gallery

Advertising  Info

Contact

 

India To Create Board To Evaluate Medical Devices

India’s Department of Health Research (DHR) is planning to establish a Medical Technology Assessment Board (MTAB) to evaluate all types of new and existing medical technologies.

The MTAB will foster the development of medtech innovations that will help reduce healthcare costs, improve patient care and streamline the medical reimbursement procedures. Pharmabiz.com cites sources that claim steps already have been taken to set up the board and get it operating, though no specific timetable is mentioned.

The 12th Plan Working Group on Health Research recommended the establishment of an MTAB. After considering the recommendation, India’s government decided to create the MTAB to evaluate the need and cost effectiveness of new and available medical technologies in the country, pharmabiz’s sources added.

The government plans to consult technology generators, industry, regulators, economists, user groups and experts knowledgeable about similar models from the United Kingdom, Canada, Australia, Thailand and other countries before establishing the MTAB. The new agency will be a part of the overall regulatory / promotional structure being established in the DHR to accelerate indigenous production of health products/instruments / medical devices.

As part of the initiative, a Memorandum of Understanding has been signed between the DHR and the National Institute of Clinical Excellence (NICE) in the United Kingdom. The two entities are now identifying areas where they can collaborate on and exchange knowledge about NICE regulatory (first phase) procedures. An Apex Advisory Committee to set up the board has been formed and is functional, sources added.

A Parliamentary panel also has called for early action in setting up the MTAB. “The MTAB is proposed to be assigned with very critical activities. However, the reply of the Department does not indicate any time frame within which the MTAB would become functional. A timeline may be fixed for completing the task,” the panel said.

(Ref: http://www.mpo-mag.com/contents/view_breaking-news/2014-03-20/india-tocreate-board-to-evaluate-medicaldevices/)


Antimicrobial Plastics Market: Healthcare / Medical Sector Is By Far The Indisputable Winner

Undoubtedly the Healthcare/Medical sector emerges as first consumer of antimicrobial, far ahead of packaging according to the recent Click ‘N Vote ‘For which market will the use of antimicrobials grow the most?’ 2014 results are on line with the 2010 click N’ vote results as shown on the Figure 1 below.

Figure 1: Market to Witness Highest Growth in Antimicrobials Comparision of March 2010 {220 votes} & April 2014 {122 votes} Results) Gathered from SpecialChem4Polymers Community Results of the Survey

In fact those similar results hide an intricate and dynamic evolution due to new trends: more stringent requirements, higher demand, government regulations, wider range of products used every day, new environmental trends, new additives, specific solutions. These various industrial sectors have very different requirements as varied as safety, lifetime increase, aesthetics, unpleasant odor suppression and sometimes simply marketing arguments.

Devices are as heterogeneous as medical devices, packaging products, sports and recreation equipment, Food processing machinery, business machines, consumer appliances, general household goods, transportation interiors, construction supplies, outdoor applications and compounds that use organic fillers.

In addition to technical and economic requirements, the growth of antimicrobial plastics depends on specific legislative pressures. In the United States, usage and benefit claims are regulated by the EPA or guided by the FDA depending on usage. In Europe, The Biocidal Products Regulation (BPR, Regulation (EU) 528/2012) concerns the placing on the market and use of biocidal products. All biocidal products require an authorization before they can be placed on the market, and the active substances contained in that biocidal product must be previously approved.

All antimicrobial agents have different activities and varying influences on microorganisms, so every type of antimicrobial solution must be studied separately depending on the microorganism(s) to be fought.

Antimicrobial solutions include, for example, inorganic derivatives of Silver, Copper, Zinc and organic products such as BIT (Benzisothiazoline-one), DCOIT (Dichloro-octyl-4-isothiazolin-one), OIT (Octyl-isothiazolin-one), OBPA (oxybisphenoxarsine), IPBC (iodopropynyl butylcarbamate), TBT (tributyltin), TBZ (Thiazolyl benzimidazole), Triclosan, Zinc pyrithione... Of course nanomaterials are also used and studied.

As for other new and growing technologies, there are many controversies concerning the antimicrobial spreading in the environment, the possible harmful effect of certain entities notably for long-term use, the possible bacterial resistance and/or hormonal disruption, the efficiency of some products in preventing illness and curtailing infection.

Healthcare / Medical Sector:

Complex epidemiological situation, nosocomial infections, microbial contamination, and infection risks in hospital and dental equipment have led to an ever-growing need for prevention of microbial infection in these various areas.

Antibiotic resistance is a serious and growing phenomenon and has emerged as one of the pre-eminent public health concerns of the 21st century. A World Health Organization report states that this serious threat is no longer a prediction but is happening right now in every region of the world and can affect anyone, of any age, in any country.

Prevention technologies are vital weapons in the battle against infection and antimicrobial solutions help enhancing infection prevention and control. A growing interest in recycling some disposable medical products continues to create opportunities for antimicrobial solutions.

Antimicrobial solutions are used in hospitals, dental surgeries, care homes and GP practices for products ranging from beds, cubicle curtains, nurse call systems, wall and ceiling paints, floors, door handles, handrails, pull cords, and case note holders.

(Ref: http://www.specialchem4polymers.com/community-pulse/communityinsight.aspx?id=10677 )

Other News

Experts Miffed Over Delay In NIPER Campus In Gandhinagar
How Technology Is Changing The Face Of Indian Healthcare
Biotech Strategy To Develop Simple, Rapid, Indigenous, Low Cost Medical Devices & Implants
Medtech Start-up Develops Germ-killing Catheter

Archives

Advertisement

 

 


Back | Back To Top | Previous | Next